Drug company executives are honest in replying in the hearing. But they will do nothing to reduce prices. They want to keep shareholders happy. All the money received by shareholders will come back to pharmaceutical companies when they will be required to pay as patients. It all goes around.
PBM
Drug company executives are honest in replying in the hearing. But they will do nothing to reduce prices. They want to keep shareholders happy. All the money received by shareholders will come back to pharmaceutical companies when they will be required to pay as patients. It all goes around.